Ocuphire Pharma, Inc. (OCUP) Financials
OCUP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 53.9 million | 4.0 million |
2023-09-30 | 54.2 million | 3.9 million |
2023-06-30 | 43.5 million | 5.8 million |
2023-03-31 | 45.4 million | 4.2 million |
OCUP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 4.5 million | 711000 |
2023-09-30 | -3.0 million | 573000 |
2023-06-30 | 989000 | 1.4 million |
2023-03-31 | -3.6 million | 804000 |
OCUP Net Income
No data available :(
OCUP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 50.5 million | - | - |
2023-09-30 | 42.4 million | - | - |
2023-06-30 | 40.0 million | - | - |
2023-03-31 | 39.0 million | - | - |
OCUP Shares Outstanding
OCUP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 3.8 million | 3.3 million | - |
2023-09-30 | - | 3.5 million | 2.1 million | - |
2023-06-30 | - | 4.7 million | 4.3 million | - |
2023-03-31 | - | 5.6 million | 2.3 million | - |
OCUP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.7 million | 3000 |
2023-09-30 | 11.9 million | 1000 |
2023-06-30 | 3.7 million | 1000 |
2023-03-31 | 1.7 million | 1000 |
OCUP
Price: $1.61
52 week price:
Earnings Per Share: -0.46 USD
P/E Ratio: 1.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 340500
Market Capitalization: 47.4 million